Generex Launches Generex Oral-lyn In Algeria

Generex Biotechnology (Generex) together with Continental Pharma Laboratories, the company’s importation, marketing, distribution, and sales agent in Algeria, has reported the launch of commercial sales of Generex Oral-lyn in Algeria.

Reportedly, the product has been approved for importation and commercial marketing and sale in Algeria, and will be marketed and sold for the treatment of patients with Type-1 or Type-2 diabetes.

Bill Abajian, executive advisor of global licensing and business development at Generex, said: “It is with great enthusiasm that we launch Generex Oral-lyn in Algeria with our distribution partner, Continental Pharma. While we continue to make progress in the Middle Eastern theater, our second commercial launch in the region (Lebanon and now Algeria) will provide great exposure to our novel and unique drug product. Over the course of both launches, more than 200 endocrinologists have been educated about the application of Generex Oral-lyn and that figure will continue to grow as additional training sessions take place.”